09:52 AM EST, 01/22/2025 (MT Newswires) -- Edgewise Therapeutics ( EWTX ) said Wednesday it promoted Chief Business Officer Behrad Derakhshan to chief operating officer.

The company also said it named Robert Blaustein as chief development officer.

Blaustein previously served as associate vice president and the atherosclerosis section head in the atherosclerosis and metabolism clinical research department at Merck ( MRK ) , Edgewise said.

Edgewise said the changes to its executive team took effect immediately.

The company's shares were down 4% in recent trading.

Price: 26.31, Change: -1.08, Percent Change: -3.94